Skip to content

Clinical trials

Completed Purpura, Thrombocytopenic, Idiopathic trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Status: Completed Country / region: Austria Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20142
20151
20171
20182
20191
20202
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
argenx3
Novartis Pharmaceuticals2
Rigel Pharmaceuticals2
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Amgen1
GlaxoSmithKline1
Medical University of Graz1
Octapharma1
Principia Biopharma, a Sanofi Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic13
Anemia, Hemolytic, Autoimmune2
Purpura2
Thrombocytopenia2
Anemia, Aplastic1
Anemia, Hemolytic1
Hemorrhage1
Myelodysplastic Syndromes1
Pancytopenia1
Primary Immunodeficiency Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.